This story has been updated from a previous version.

NEW YORK, May 24 - A SNP initiative coordinated by the Japanese government has chosen Third Wave Technologies to provide the assays for analyzing at least 120,000 SNPs in 768 patients, the company said Thursday. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.